Julian Downward

45PUBLICATIONS
313CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersComputational imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jun 08, 2026
KRAS Inhibitor Induced Cancer Cell Death Enhances Sensitivity to Immune-Mediated Bystander Killing of Drug-Resistant Subclones.

|Jun 01, 2026
Sensitizing Lung Cancer to Immunotherapy with a RAS(ON) Inhibitor Doublet.

|Apr 19, 2026
A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.

|Jan 14, 2026
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Kevin W Ng, Jesse Boumelha, Katey S S Enfield

|Oct 09, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2.

Joseph E Klebba, Nilotpal Roy, Steffen M Bernard

|Jul 16, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored Immunotherapy.

Rishita Chatterjee, Arturo Simoni-Nieves, An Truong

Pageof 8

Frequent Collaborators

13 joint publications

Miriam Molina-Arcas

13 joint publications

Charles Swanton

9 joint publications

Christopher Moore

6 joint publications

Katey S S Enfield